Repository logo

Browsing by Author "Canonica, G Walter"

Now showing 1 - 4 of 4
  • Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms
    Publication . Bousquet, Jean; Schröder-Bernhardi, Detlef; Bachert, Claus; Canonica, G Walter; Cardona, Victoria; Costa, Elísio; Czarlewski, Wienczyslawa; Devillier, Philippe; Fonseca, Joao A; Klimek, Ludger; Kuna, Piotr; Lourenço, Olga; Mullol, Joaquim; Pfaar, Oliver; Pham-Thi, Nhân; Samolinski, Boleslaw; Saueressig, Julia; Scadding, Glenis K; Stroh, Ann-Kathrin; Scheire, Sophie; Van Ganse, Eric; Zuberbier, Torsten
    Background: The practice of allergology varies widely between countries, and the costs and sales for the treatment of rhinitis differ depending on practices and health systems. To understand these differences and their implications, the rhinitis market was studied in some of the EU countries. Methods: We conducted a pharmaco-epidemiological database analysis to assess the medications that were being prescribed for allergic rhinitis in the years 2016, 2017 and 2018. We used the IQVIA platforms for prescribed medicines (MIDAS®- Meaningful Integration of Data, Analytics and Services) and for OTC medicines (OTC International Market Tracking-OTCims). We selected the five most important markets in the EU (France, Germany, Italy, Poland and Spain). Results: Intranasal decongestants were excluded from the analyses because they are rarely prescribed for allergic rhinitis. For both Standard Units (SU) and costs, France is leading the other countries. In terms of SU, the four other countries are similar. For costs, Poland is lower than the three others. However, medication use differs largely. For 2018, in SU, intranasal corticosteroid is the first treatment in Poland (70.0%), France (51.3%), Spain (51.1%) and Germany (50.3%), whereas the Italian market is dominated by systemic antihistamines (41.4%) followed by intranasal corticosteroids (30.1%). Results of other years were similar. Discussion: There are major differences between countries in terms of rhinoconjunctivitis medication usage.
    2021-04-20Journal article Open access Show more
  • Management of anaphylaxis due to COVID-19 vaccines in the elderly
    Publication . Bousquet, Jean; Agache, Ioana; Blain, Hubert; Jutel, Marek; Ventura, Maria Teresa; Worm, Margitta; Del Giacco, Stefano; Benetos, Athanasios; Bilo, M Beatrice; Czarlewski, Wienczyslawa; Abdul Latiff, Amir; Cruz, Alvaro A; Dokic, Dejan; El-Gamal, Yehia; Atanaskovic-Markovic, Marina; Mullol, Joaquim; Khaitov, Musa; Louis, Renaud; Fernandez-Rivas, Montserrat; Fokkens, Wytske J; Fonseca, Joao A; Nekam, Kristof; O'Hehir, Robyn; Le Thi Tuyet, Lan; Miot, Stéphanie; Passalacqua, Giovanni; Lourenço, Olga; Namazova-Baranova, Leyla; Hofmann, Maja; Hrubisko, Martin; lenaIllario, Madda; Pfaar, Oliver; Niedoszytko, Marek; Popov, Todor A; Montella, Emma; Okamoto, Yoshitaka; Rondon, Carmen; Neffen, Hugo; Patella, Vincenzo; Knol, Edward; Kraxner, Helga; Kuna, Piotr; Salles, Nathalie; Odemyr, Mikaëla; Pham-Thi, Nhân; Le Moing, Vincent; Ollert, Markus; Recto, Marysia T; Scichilone, Nicola; Petrovic, Mirko; Rottem, Menachem; Mahler, Vera; Martin, Finbarr C; Matucci, Andrea; Hoffmann, Hans Jürgen; Skypala, Isabel; Plavec, Davor; Samolinski, Boleslaw; Almeida, Mário Morais; Regateiro, Frederico S; Mortz, Charlotte G; Sturm, Gunter; Rouadi, Philip W; Sediva, Anna; Torres, Maria; Santos, Alexandra F; Smolinska, Sylwia; Palomares, Oscar; Papadopoulos, Nikolaos G; Panzner, Petr; Valiulis, Arunas; Wallace, Dana; Shamji, Mohamed H; Suppli Ulrik, Charlotte; Zernotti, Mario; Sokolowska, Milena; Untersmayr, Eva; Roller-Winsberger, Regina E; Rolland, Yves; Romano, Antonino; Akdis, Cezmi A; Vitte, Joana; Al-Ahmad, Mona; Todo-Bom, Ana; Walusiak-Skorupa, Jolanta; Bennoor, Kazi Saifuddin; Urrutia-Pereira, Marilyn; Zidarn, Mihaela; Serpa, Faradiba Sarquis; Sastre, Joaquin; Schols, Jos M G A; Bosnic-Anticevich, Sinthia; Vultaggio, Alessandra; Zuberbier, Torsten; Sheikh, Aziz; Wang, De-Yun; Angier, Elizabeth; Carreiro-Martins, Pedro; Chivato, Tomas; Berghea, Elena Camelia; Sousa-Pinto, Bernardo; Sova, Milan; Stelmach, Rafael; Reynes, Jacques; Cherubini, Antonio; Klimek, Ludger; Brockow, Knut; Toppila-Salmi, Sanna; Annesi-Maesano, Isabella; Tsiligianni, Ioanna; Ebisawa, Motohiro; Bindslev-Jensen, Carsten; Carriazo, Ana; Gao, Yadong; Brussino, Luisa; Christoff, George; Waserman, Susan; Yorgancioglu, Arzu; Yusuf, Osman; Gelincik, Asli; Guérin, Olivier; Casale, Thomas; Eberlein, Bernadette; Irani, Carla; Chu, Derek K; Gavazzi, Gaëtan; Bachert, Claus; Barbaud, Annick; Bedbrook, Anna; Julge, Kaja; Gemicioglu, Bilun; Bonini, Sergio; Farrell, John; Haahtela, Tari; Kvedarienė, Violeta; Gawlik, Radolslaw; Ispayeva, Zhanat; Camargos, Paulo; Canonica, G Walter; Cardona, Victoria; Levin, Michael; Gotua, Maia; Kaidashev, Igor; Caubet, Jean-Christoph; Hoffmann-Sommergruber, Karin; Cecchi, Lorenzo; Milenkovic, Branislava; Ivancevich, Juan Carlos; Lauerma, Antti
    Older adults, especially men and/or those with diabetes, hypertension and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritised to receive COVID-19 vaccines due to high risk of death. In very rare instances,the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society)Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients.
    2021-04-02Journal article Open access Show more
  • Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
    Publication . Lourenço, Olga; Bosnic-Anticevich, Sinthia; Costa, Elísio; Fonseca, Joao A; Menditto, Enrica; Cvetkovski, Biljana; Kritikos, Vicky; Tan, Rachel; Bedbrook, Anna; Scheire, Sophie; Bachert, Claus; Białek, Sławomir; Briedis, Vitalis; Boussery, Koen; Canonica, G Walter; Haahtela, Tari; Kuna, Piotr; Novellino, Ettore; Samolinski, Boleslaw; Schünemann, Holger J; Wallace, Dana; Bousquet, Jean
    The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines.
    2020-05-16Journal article Open access Show more
  • Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)
    Publication . Bousquet, Jean; Pham-Thi, Nhân; Bedbrook, Anna; Agache, Ioana; Annesi-Maesano, Isabella; Ansotegui, Ignacio; Anto, Josep M.; Bachert, Claus; Benveniste, Samuel; Bewick, Mike; Billo, Nils; Bosnic-Anticevich, Sinthia; Bosse, Isabelle; Brusselle, Guy; Calderon, Moïses A; Canonica, G Walter; Caraballo, Luis; Cardona, Victoria; Carriazo, Ana Maria; Cash, Eugene; Cecchi, Lorenzo; Chu, Derek K; Colgan, Elaine; Costa, Elísio; Cruz, Alvaro A; Czarlewski, Wienczyslawa; Durham, Stephen; Ebisawa, Motohiro; Erhola, Marina; Fauquert, Jean-Luc; Fokkens, Wytske J; Fonseca, Joao A; Guldemond, Nick; Iinuma, Tomohisa; Illario, Maddalena; Klimek, Ludger; Kuna, Piotr; Kvedarienė, Violeta; Linnemann, Désirée Larenas; Laune, Daniel; Le Thi Tuyet, Lan; Lourenço, Olga; Malva, Joao O; Marien, Gert; Menditto, Enrica; Mullol, Joaquim; Münter, Lars; Okamoto, Yoshitaka; Onorato, Gabrielle L; Papadopoulos, Nikos G; Perala, Maritta; Pfaar, Oliver; Phillips, Abigail; Phillips, Jim; Pinnock, Hilary; Portejoie, Fabienne; Quinones-Delgado, Pablo; Rolland, Christine; Rodts, Ulysse; Samolinski, Boleslaw; Sanchez-Borges, Mario; Schünemann, Holger J; Shamji, Mohamed; Somekh, David; Togias, Alkis; Toppila-Salmi, Sanna; Tsiligianni, Ioanna; Usmani, Omar; Walker, Samantha; Wallace, Dana; Valiulis, Arunas; van der Kleij, Rianne; Ventura, Maria Teresa; Williams, Sian; Yorgancioglu, Arzu; Zuberbier, Torsten
    In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative (2), and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) (3), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs—centred around the patient with rhinitis and using mHealth monitoring of environmental exposure. An expert meeting took place at the Pasteur Institute in Paris, December 3, 2018. The aim was to discuss nextgeneration care pathways following an ongoing political agenda (4,5): (I) patient participation, health literacy and self-care through technology-assisted “patient activation”; (II) implementation of care pathways by pharmacists and (III) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) assessed by mobile technology. The present document reviews the workshop report and follows on from Part 1.
    2019-09Journal article Open access Show more